Precision Vaccines Program | Overview
Based in the Division of Infectious Diseases at Boston Children’s Hospital, the Precision Vaccines Program (PVP) is an academic research program discovering and developing the next generation of vaccines tailored to vulnerable populations. We conduct basic and translational research to develop novel vaccines and therapeutics for diseases that especially affect vulnerable populations such as infants, older adults and distinct immunocompromised populations.
Our program team is composed of experts in vaccinology, clinical trials, immunology, molecular biology, administration, data management, biostatistics, bioinformatics, and systems biology. We foster international collaboration among academia, government and industry to achieve the mission and advance technologies. We invite you to join our Precision Vaccines Network that advances this mission
What are Precision Vaccines?
There is a growing realization that vaccine responses vary with an individual’s characteristics including age, sex, and environmental setting. The Precision Vaccines Program applies precision medicine principes to vaccinology thereby optimizing vaccines specific to vulnerable populations, particularly those at greatest risk of infection: the young, older adults, and the immunocompromised.
Dr. Ofer Levy’s TedTalk: The New Science of Personalized Vaccines (November 2019)
Dr. Ofer Levy’s TedxBoston: Precision Vaccines: Lessons Learned from the Coronavirus Pandemic (November 2021)